DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Neutral red uptake assay are 26

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_2936	Chloroquine	Antiparasitic products, Insectisides and Repellents	Malaria	Chikungunya virus	DRDE-06	NA	Neutral red uptake assay	Decrease (50 %)	Approved	20336760
DrugRepV_2937	Chloroquine	Antiparasitic products, Insectisides and Repellents	Malaria	Chikungunya virus	DRDE-06	NA	Neutral red uptake assay	Decrease (50 %)	Approved	20336760
DrugRepV_2938	Chloroquine	Antiparasitic products, Insectisides and Repellents	Malaria	Chikungunya virus	DRDE-06	NA	Neutral red uptake assay	Decrease (50 %)	Approved	20336760
DrugRepV_2939	Chloroquine	Antiparasitic products, Insectisides and Repellents	Malaria	Chikungunya virus	DRDE-06	NA	Neutral red uptake assay	Decrease (90 %)	Approved	20336760
DrugRepV_2940	Chloroquine	Antiparasitic products, Insectisides and Repellents	Malaria	Chikungunya virus	DRDE-06	NA	Neutral red uptake assay	Decrease (90 %)	Approved	20336760
DrugRepV_2941	Chloroquine	Antiparasitic products, Insectisides and Repellents	Malaria	Chikungunya virus	DRDE-06	NA	Neutral red uptake assay	Decrease (90 %)	Approved	20336760
DrugRepV_5225	Ribavirin	Antiinfectives For Systemic Use	Hepatitis C virus	Crimean-Congo hemorrhagic fever virus	IbAr 10200	NA	Neutral red uptake assay	Decrease (50 %)	Approved	15026198
DrugRepV_5226	Ribamidine	NA	NA	Crimean-Congo hemorrhagic fever virus	IbAr 10200	NA	Neutral red uptake assay	Decrease (50 %)	Investigational	15026198
DrugRepV_5227	6-Azauridine	NA	Cancer	Crimean-Congo hemorrhagic fever virus	IbAr 10200	NA	Neutral red uptake assay	Decrease (50 %)	NA	15026198
DrugRepV_5228	Selenazofurin	NA	NA	Crimean-Congo hemorrhagic fever virus	IbAr 10200	NA	Neutral red uptake assay	Decrease (50 %)	NA	15026198
DrugRepV_5229	Tiazofurin	Antineoplastic and Immunomodulating Agents	Cancer	Crimean-Congo hemorrhagic fever virus	IbAr 10200	NA	Neutral red uptake assay	Decrease (50 %)	Experimental	15026198
DrugRepV_5230	Ribavirin	Antiinfectives For Systemic Use	Hepatitis C virus	Crimean-Congo hemorrhagic fever virus	Spu 128/81	NA	Neutral red uptake assay	Decrease (50 %)	Approved	15026198
DrugRepV_5231	Ribamidine	NA	NA	Crimean-Congo hemorrhagic fever virus	Spu 128/81	NA	Neutral red uptake assay	Decrease (50 %)	Investigational	15026198
DrugRepV_5232	6-Azauridine	NA	Cancer	Crimean-Congo hemorrhagic fever virus	Spu 128/81	NA	Neutral red uptake assay	Decrease (50 %)	NA	15026198
DrugRepV_5233	Selenazofurin	NA	NA	Crimean-Congo hemorrhagic fever virus	Spu 128/81	NA	Neutral red uptake assay	Decrease (50 %)	NA	15026198
DrugRepV_5234	Tiazofurin	Antineoplastic and Immunomodulating Agents	Cancer	Crimean-Congo hemorrhagic fever virus	Spu 128/81	NA	Neutral red uptake assay	Decrease (50 %)	Experimental	15026198
DrugRepV_5235	Ribavirin	Antiinfectives For Systemic Use	Hepatitis C virus	Crimean-Congo hemorrhagic fever virus	Hy-13	NA	Neutral red uptake assay	Decrease (50 %)	Approved	15026198
DrugRepV_5236	Ribamidine	NA	NA	Crimean-Congo hemorrhagic fever virus	Hy-13	NA	Neutral red uptake assay	Decrease (50 %)	Investigational	15026198
DrugRepV_5237	6-Azauridine	NA	Cancer	Crimean-Congo hemorrhagic fever virus	Hy-13	NA	Neutral red uptake assay	Decrease (50 %)	NA	15026198
DrugRepV_5238	Selenazofurin	NA	NA	Crimean-Congo hemorrhagic fever virus	Hy-13	NA	Neutral red uptake assay	Decrease (50 %)	NA	15026198
DrugRepV_5239	Tiazofurin	Antineoplastic and Immunomodulating Agents	Cancer	Crimean-Congo hemorrhagic fever virus	Hy-13	NA	Neutral red uptake assay	Decrease (50 %)	Experimental	15026198
DrugRepV_5240	Ribavirin	Antiinfectives For Systemic Use	Hepatitis C virus	Crimean-Congo hemorrhagic fever virus	UG3010	NA	Neutral red uptake assay	Decrease (50 %)	Approved	15026198
DrugRepV_5241	Ribamidine	NA	NA	Crimean-Congo hemorrhagic fever virus	UG3010	NA	Neutral red uptake assay	Decrease (50 %)	Investigational	15026198
DrugRepV_5242	6-Azauridine	NA	Cancer	Crimean-Congo hemorrhagic fever virus	UG3010	NA	Neutral red uptake assay	Decrease (50 %)	NA	15026198
DrugRepV_5243	Selenazofurin	NA	NA	Crimean-Congo hemorrhagic fever virus	UG3010	NA	Neutral red uptake assay	Decrease (50 %)	NA	15026198
DrugRepV_5244	Tiazofurin	Antineoplastic and Immunomodulating Agents	Cancer	Crimean-Congo hemorrhagic fever virus	UG3010	NA	Neutral red uptake assay	Decrease (50 %)	Experimental	15026198